Articles On Adherium (ASX:ADR)
Title | Source | Codes | Date |
---|---|---|---|
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Health minnow 1st Group climbs on new contract in WA
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Orexplore’s 150pc ray of BHP deal sunshine pours light on a dismal day
ASX 200 benchmark falls, gains and wanes its way to just 0.03% for the day. Real Estate, resources and gold (oh my!) lead a troubled bourse from disaster. Mining tech minnow Orexplore’s $1.55m BHP deal delivers a +150% gift for investors.... |
Stockhead | ADR | 1 year ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Tech woes and China combine to drag local markets down 1.5pc
After a steep early drop, the benchmark stabilised to close 1.5% down. InfoTech and Materials fared worst, following a mega tech sell-off on Wall Street. Loyal Lithium soared more than 37% after hitting fresh spod at Trieste. I think we... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Local markets dip 0.86pc on Chinese developer woes and other bad bets
ASX benchmark falls 0.86% for the day, dragged down by bad news from China. Telcos, Energy and InfoTech tried their best, but the overall gloom was too much to fight. Lithium Universe (ASX:LU7) banks a solid market debut as it kicks off i... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Lithium Universe hits the ASX with a big bang
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: The ASX needle has barely moved, AGL lost $1.2bn and AMP continues to suck
Local markets have risen from the dead again, closing at +0.26% for the day. Bowen Coking Coal has leapt to the top of the ladder with a 26.3% gain. Energy fought hard to hit 2.12%, but InfoTech’s -1.92% dead weight held the whole market b... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: ASX ends flat, but Azure’s inability to stop finding lithium is helping its neighbours grow
ASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care romped home to win Best Sector today, up more than 0.4% Errawarra’s nearology has continued to pay off, adding around 50% more today. Whil... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: James Hardie delivers super strong quarter; Auris digs up more gold
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Adherium announces collaboration agreement with major US asthma practice
Digital health company Adherium (ASX:ADR) has signed a collaboration agreement with US-based Allergy Partners with the aim of transforming asthma management for its more than 300,000 patients across 130 sites in 20 states. |
BiotechDispatch | ADR | 1 year ago |
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | ADR | 1 year ago |
ASX July Winners: Easing inflation, AI, and an oil rally lure sidelined traders back to risky assets
The ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best and worst performing ASX stocks for the month For the month of July, most major indexes on the ASX rose by around 2.5%. Name % Change... |
Stockhead | ADR | 1 year ago |
Closing Bell: ASX falls flat after strong employment data muddies waters
The ASX 200 built a platform for success today. Which failed. It fell flat at close Sectors wise, Financials, IT and Industrials did okay. The others, very much including Health Care and Utilities, didn’t Notable performers today: Nuix (AS... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Super gold hits, lithium nearology, and a potential niobium discovery
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | ADR | 1 year ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | ADR | 1 year ago |
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May There are clear signs the biotech sector is springing back to life after a disappointing 2... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: A massive win for Zelira’s new pain drug has polished an absolute turd of a day
The ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the market mid-morning, because rate hikes are on the way Two Small Caps hit triple-figure home runs today, which is kinda amazing Welp… that was... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: These ASX graphite and copper players are leading the pack in early trade
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week Earlier this week, Pfizer surprised the market by say... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: It’s just another mediocre Monday as the market falters by 0.45%
The ASX 200 benchmark waddled its way to a regrettable 0.45% end to the day Materials the only sector to close on a positive note, up 0.22% Power Minerals wins the day with a canny move from copper-gold to lithium There wasn’t a whole l... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Mega gold merger outweighs bankers’ ex-div dive, leaving the ASX up 0.1%
After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike As far as days on the ASX go, that definitely... |
Stockhead | ADR | 1 year ago |
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit Medicare, telehealth and mental... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds
ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree The ASX h... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: The ASX goes down, the Goldies go up, because that’s the way of the world
The ASX 200 turned Hump Day into Slump Day, dropping 1.1% Goldies shone bright under trying conditions to be up more than 2.6% Greentech Metals went ham on the gains, adding 200% while the rest of the market wept Things haven’t really i... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Copper finds and impressive March quarter results
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | ADR | 1 year ago |
Closing Bell: ASX200 gains but small caps edge lower; Polymetals soars on thick high-grade drill results
The S&P ASX 200 closed up 0.2%, while the S&P XEC fell 0.61% Polymetal Resources soars 64% after announcing thick high grade drill hits at Endeavour polymetallic mine XTEK subsidiary HighCom Armour Solutions signs a collaboration d... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Which ASX explorer just exploded 122pc at the open?
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: ASX closes higher to end week, materials leading bourse upwards
ASX closes up 0.78%, while XEC rises 1.91% following global markets higher Morningstar warns of possible start of US recession next week spanning 3 quarters, but talk of pause in Aussie rate hikes ‘premature’ Hubify subsidiary Broadland So... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: These ASX fintech, biotech and gold stocks are flying on Friday
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: ASX closes higher with Tech stocks leading the way
ASX closes up ~1%, while XEC rises 1.21% following global markets higher Rabobank expects the RBA to raise rates by 0.25% at its April meetig Alice Queen gets funding boost from Queensland Government for Horn Island exploration The posi... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Be honest. If the Energy sector was a horse right now, you’d shoot it
ASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0% because it wants to watch you cry in the shower Low unemployment data sets up the RBA to keep twisting Australia’s nipples, just the way we... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: The ASX stocks laughing all the way to the bank early trade Monday
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Gold, nickel finds and Orphan Drug Designation for a pharmaceutical player
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Surely we’ve all completely lost interest in talking about interest rates by now
ASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had better news for Aussies. Kind of Summit Resources galloped to a win, up 35% on great REE news at Stallion We have comments from US Fed chair... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: The gold, copper and HR stocks leading the winners in early trade Friday
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Aussies find a cost of living crisis fix, by stealing everything not nailed down
The ASX slid to close flat today, after realising we were in danger of making some money Materials and Energy enjoyed a boost from Chinese manufacturing data Retail theft rates have soared as the cost of living crisis hits hard around the... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Back from the dead, the ASX delivers in a George A Romero slow-zombie classic
The ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers from early flesh wounds to end the day flat Ordinary Aussies ‘outraged’ over changes to super that will never, ever affect them The market has... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: These ASX seafood, copper and rare earths stocks are getting snapped up in early trade
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
CLOSING BELL: Forcing the product to pay to be the product is about as Meta as it gets
The ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month for the privilege of being a captive audience Some Big Names have had shockers as earnings relentlessly keep rolling in The benchmark has... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: These ASX uranium, vanadium and gold stocks look marvellous on Monday morning
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Top 10 at 10: Rare earths hits, a new lithium prospect and an acquisition wraps up
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | ADR | 1 year ago |
Trading Places, Director Trades: Who’s got faith in scandal-plagued Star Entertainment Group?
Super fund Australian Retirement Trust buys into scandal-plagued Star Entertainment Group State Street Corporation ceases to be a substantial shareholder in Evolution Mining and Sandfire Resources Warrego Energy director sells down stock a... |
Stockhead | ADR | 1 year ago |
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care
The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry The US FDA announced last week that:... |
Stockhead | ADR | 1 year ago |
Closing Bell: ASX drops, and a waste management stock gets takeover offer
The ASX 200 dropped 0.30% and the ASX XEC declined 0.20% Only 4 out of 11 sectors were higher, with Utilities leading the way Waste management company M8 Sustainable receives unsolicited takeover offer The ASX 200 declined 0.30% today,... |
Stockhead | ADR | 1 year ago |
Closing Bell: Elon Musk says we dont need extra copper and lithium is easy to mine. The experts disagree
The ASX 200 rose up 0.07%, ASX XEC was up 0.57% Only 6 out of 11 sectors were higher, with Tech leading the way Earlier today, Elon Musk said this: No change in copper production is required for the transition to sustainable energy. L... |
Stockhead | ADR | 1 year ago |
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past... |
Stockhead | ADR | 1 year ago |
Adherium awarded UK National Health Service’s SBRI healthcare monitoring project
Adherium (ASX:ADR) has announced an award for a pathfinder service development project from the UK National Health Service’s Small Business Research Initiative Healthcare. |
BiotechDispatch | ADR | 1 year ago |